CHRISTOPHER RICHARD 4
4 · Lexaria Bioscience Corp. · Filed Dec 3, 2024
Insider Transaction Report
Form 4
CHRISTOPHER RICHARD
DirectorChief Executive Officer
Transactions
- Purchase
common shares
2024-12-02$2.24/sh+22,828$51,217→ 22,828 total - Purchase
common shares
2024-12-03$2.47/sh+27,172$67,175→ 50,000 total
Holdings
- 200,000
Stock Options
Exercise: $3.92From: 2025-02-28Exp: 2029-08-31→ Common Shares (200,000 underlying)
Footnotes (1)
- [F1]Options are vested as to 50,000 on February 28, 2025 with 6,818 being vested monthly thereafter until November 30, 2026 whereby the balance of 6,822 options will be vested on December 31, 2026